Table 10.4.
Recent in vivo studies on the efficacy of orally administered immunoglobulin preparations on health
Antigen used in immunization | Disease or condition | Treatment regimen | Treatment effect | Reference |
---|---|---|---|---|
S. mutans and S. sobrinus whole cell vaccine | Dental caries | Mouth rinse 3 times daily for 3 days (human volunteers) | Higher resting pH and smaller proportion of S. mutans in dental plaque | Loimaranta et al. (1999) |
Virulence factors of S. mutans | Dental caries | Mouth rinse twice per day for 14 days by 10 ml of immune milk (human volunteers) | Inhibited recolonization of S. mutans after antibiotic treatment | Shimazaki et al. (2001) |
Helicobacter feliswhole cell vaccine | Gastritis | 0.2 ml of immune whey (7.5% IgG) before infection or 3 times daily for 4 weeks in treatment of infected mice | Prevented infection in non-infected mice and decreased gastric inflammation and colonization in readily infected mice | Marnila et al. (2003) |
Helicobacter pyloriurease | Gastritis | 150 ml of yogurt with 1% avian IgY and probiotic bacteria 3 times daily for 4 weeks | Decreased values in urea breath test indicating decrease in colonization | Horie et al. (2004) |
No immunization | EHEC-colitis | Colostral preparation IMMULACT® to mice ad libitum (around 300 mg per day) for 3 weeks | Decreased rapidly EHEC colonization and decresed attachment to cecum walls and decreased mortality in mouse | Funatogawa et al. (2002) |
Polyvalent or monovalent E. coli vaccine | Diarrhea | IgG supplemented baby formula, daily dose 0.5 g of IgG per kg of body weight | Lower incidence of diarrhea and shorter duration of diarrhea episodes in human infants during follow-up period for 6 months | Tawfeek et al. (2003) |
Shigella dysenteriaeantigen I | Shigellosis | 100 ml orally 3 times per day for 3 days in combination with antibiotics | No significant difference in any clinical parameter | Ashraf et al. (2001) |
No immunization | HIV-associated diarrhea | Colostral preparation ColoPlus® to HIV-associated diarrhea patients for 7 weeks | Substantial decrease in stool frequency and in fatigue and increase in body weight | Florén et al. (2006) |
Cocktail of 17 strains of pathogenic diarrhea bacteria | E. coli and Salmonella diarrhea | Orally 10 mg of specific Ig per day for 10 days starting 6 or 8 days before infection | Prevented enteroinvasive E. coli and Salmonella typhi diarrhea and normalized immunological parameters | Xu et al. (2006) |
Cocktail of 17 strains of pathogenic diarrhea bacteria | E. coli, Salmonella and Shigella diarrhea | Orally once per day for 10 days starting 6 or 8 days before infection | Decreased the clinical signs of diarrhea and supported splenic NK-cell functions | Huang et al. (2008) |
No immunization | Murine rotavirus infection in mouse | Milk IgG fraction orally at time of infection and 12 hours post infection | Decreases rotavirus shedding in stools | Bojsen et al. (2007) |
Clostridium difficile toxin and C. difficile whole cells | C. difficile diarrhea | Orally for 2 weeks as supportive treatment after antibiotic treatment | C. difficile toxins eradicated from 15 of 16 patients and no relapses in any patient during 11-month follow-up period | Van Dissel et al. (2005) |
No immunization | Mild hypercholesterolemia | Orally 5 g of blood derived IgG daily for 3 or 6 weeks | Both total cholesterol and LDL levels decreased from baselines | Earnest et al. (2005) |
No immunization | Upper respiratory tract infections | 60 g of colostral protein daily for 8 weeks | Reduced significantly incidence of self-estimated symptoms of respiratory infections but no difference in duration | Brinkworth and Buckley (2003) |
No immunization | Endotoxemia due to abdominal surgery | Colostral product Lactobin® 52 g daily in 4 doses orally for 3 days before surgery | Lower levels of endotoxin and endotoxin neutralizing capacity in blood suggesting reduced endotoxemia due to surgery | Bölke et al. (2002a) |
No immunization | Endotoxemia due to coronary surgery | Colostral product Lactobin® 42 g daily doses orally for 2 days before surgery | Lower levels of CRP but no effect on perioperative endotoxemia | Bölke et al. (2002b) |
Parts of this table compiled and edited from Korhonen et al. (2000) and Mehra et al.. (2006).